Clinical Trials List
Protocol NumberTBCGHPZ20240826
Active
2025-05-01 - 2028-12-31
Phase II
Recruiting1
ICD-10C76.0
Malignant neoplasm of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9195.0
Malignant neoplasm of other and ill-defined sites of head, face and neck
-
Trial Applicant
TAIWAN BIOTECH CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Yi-Wei Chen Division of Radiation Therapy
- 戴世光 Division of Otolaryngology
- 吳欣蔚 Division of Radiology
- 吳嘉紘 Division of Radiology
- 李家誠 Division of Radiation Therapy
- Mu-Hsin Chang Division of Hematology & Oncology
- 游鎧蔚 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
16 participants
